US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 29.960
  • -0.450-1.48%
Close Nov 22 16:00 ET
  • 29.960
  • 0.0000.00%
Post 20:01 ET
966.22MMarket Cap12.80P/E (TTM)

Collegium Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-112.16%-9M
-32.41%67.4M
123.83%61.94M
121.16%274.75M
10.57%73.34M
73.06%74.02M
146.53%99.72M
209.31%27.67M
19.96%124.23M
83.23%66.33M
Net income from continuing operations
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
-134.96%-25M
71.24%-7.2M
Operating gains losses
--4.15M
----
----
--23.5M
--0
--0
--0
--23.5M
----
----
Depreciation and amortization
12.37%41.75M
-7.54%35.47M
-7.44%35.43M
7.43%149.26M
-17.73%35.46M
-2.33%37.15M
0.53%38.36M
94.94%38.28M
101.60%138.94M
150.33%43.1M
Deferred tax
-670.79%-8.73M
-452.36%-3.51M
-9,491.30%-4.41M
74.34%-2.15M
68.65%-338K
-154.03%-1.13M
81.14%-636K
99.24%-46K
89.25%-8.39M
92.82%-1.08M
Other non cash items
-20.25%1.66M
-26.52%1.58M
-19.43%1.76M
-1.97%8.36M
-14.87%1.94M
-12.61%2.08M
-22.91%2.15M
103.73%2.18M
148.92%8.52M
193.44%2.28M
Change In working capital
-824.44%-63.95M
-105.56%-2.22M
77.41%-5.62M
270.94%21.73M
-108.93%-2.1M
258.18%8.83M
1,580.69%39.87M
24.78%-24.86M
-194.27%-12.71M
-55.85%23.55M
-Change in receivables
98.68%-190K
-178.66%-9.16M
21.01%4.83M
116.50%3.59M
-81.06%2.33M
-783.73%-14.37M
137.38%11.65M
179.76%3.99M
3.30%-21.78M
-71.54%12.28M
-Change in inventory
186.25%6.99M
-50.30%3.41M
-92.24%1.06M
-70.65%14.17M
-90.12%1.79M
-161.74%-8.1M
-58.81%6.87M
4,023.03%13.61M
2,202.53%48.27M
50,516.67%18.15M
-Change in prepaid assets
-124.23%-434K
-661.81%-11.51M
25.63%-177K
131.24%1.44M
124.93%1.4M
137.85%1.79M
-249.77%-1.51M
-135.16%-238K
-324.13%-4.61M
-141.97%-5.6M
-Change in payables and accrued expense
-338.29%-70.32M
-34.20%15.04M
73.17%-11.33M
107.31%2.53M
-494.69%-7.62M
236.92%29.51M
32.28%22.86M
-45.33%-42.22M
-187.85%-34.6M
-110.22%-1.28M
-Change in other working capital
----
----
----
----
----
----
----
----
--3K
--0
Cash from discontinued investing activities
Operating cash flow
-112.16%-9M
-32.41%67.4M
123.83%61.94M
121.16%274.75M
10.57%73.34M
73.06%74.02M
146.53%99.72M
209.31%27.67M
19.96%124.23M
83.23%66.33M
Investing cash flow
Cash flow from continuing investing activities
-6,413.95%-248.96M
78.65%-8.91M
-10,200.00%-18.13M
87.66%-70.81M
-2,569.89%-25.1M
-3,282.30%-3.82M
-8,949.24%-41.72M
99.97%-176K
-29,410.85%-573.69M
-82.52%-940K
Net PPE purchase and sale
-275.38%-244K
-382.14%-270K
-222.73%-568K
71.58%-461K
82.55%-164K
42.48%-65K
87.85%-56K
-62.96%-176K
16.56%-1.62M
-82.52%-940K
Net business purchase and sale
----
----
----
--0
--0
----
----
----
---572.07M
--0
Net investment purchase and sale
600.90%18.82M
79.27%-8.64M
---17.56M
---70.35M
---24.93M
---3.76M
---41.66M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-6,413.95%-248.96M
78.65%-8.91M
-10,200.00%-18.13M
87.66%-70.81M
-2,569.89%-25.1M
-3,282.30%-3.82M
-8,949.24%-41.72M
99.97%-176K
-29,410.85%-573.69M
-82.52%-940K
Financing cash flow
Cash flow from continuing financing activities
256.19%149.03M
-152.47%-114.21M
-179.28%-54.15M
-132.10%-140.18M
-162.66%-67.83M
-205.30%-95.41M
-88.75%-45.24M
-86.81%68.3M
589.04%436.72M
39.24%-25.82M
Net issuance payments of debt
424.10%148.55M
-70.86%-79.05M
-163.64%-45.83M
-114.89%-65.92M
-83.33%-45.83M
-83.34%-45.83M
-85.07%-46.27M
-86.09%72.02M
985.36%442.68M
-100.00%-25M
Net common stock issuance
--0
----
----
-433.31%-75M
-227.18%-25M
---50M
----
----
70.62%-14.06M
76.37%-7.64M
Proceeds from stock option exercised by employees
4.55%620K
357.15%5.72M
13.54%4.56M
-25.08%9.1M
-52.79%3.24M
114.86%593K
-19.03%1.25M
15.96%4.02M
-4.40%12.15M
193.42%6.86M
Net other financing activities
17.44%-142K
-2,570.45%-5.88M
-66.42%-12.87M
-106.75%-8.36M
-417.78%-233K
-62.26%-172K
56.95%-220K
-128.74%-7.74M
2.53%-4.04M
---45K
Cash from discontinued financing activities
Financing cash flow
256.19%149.03M
-152.47%-114.21M
-179.28%-54.15M
-132.10%-140.18M
-162.66%-67.83M
-205.30%-95.41M
-88.75%-45.24M
-86.81%68.3M
589.04%436.72M
39.24%-25.82M
Net cash flow
Beginning cash position
-38.92%173.94M
-15.58%229.66M
36.18%239.99M
-6.74%176.24M
89.93%259.58M
127.35%284.8M
149.01%272.03M
-6.74%176.24M
6.97%188.97M
-30.19%136.67M
Current changes in cash
-331.99%-108.93M
-536.34%-55.72M
-110.79%-10.34M
600.54%63.76M
-149.50%-19.59M
-321.12%-25.22M
-20.31%12.77M
220.15%95.79M
-203.48%-12.74M
680.51%39.56M
End cash Position
-74.96%65.01M
-38.92%173.94M
-15.58%229.66M
36.18%239.99M
36.18%239.99M
89.93%259.58M
127.35%284.8M
149.01%272.03M
-6.74%176.24M
-6.74%176.24M
Free cash flow
-112.50%-9.24M
-32.65%67.13M
123.20%61.37M
123.71%274.29M
11.91%73.17M
73.37%73.95M
149.23%99.67M
208.15%27.5M
20.66%122.61M
83.24%65.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -112.16%-9M-32.41%67.4M123.83%61.94M121.16%274.75M10.57%73.34M73.06%74.02M146.53%99.72M209.31%27.67M19.96%124.23M83.23%66.33M
Net income from continuing operations -54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M-134.96%-25M71.24%-7.2M
Operating gains losses --4.15M----------23.5M--0--0--0--23.5M--------
Depreciation and amortization 12.37%41.75M-7.54%35.47M-7.44%35.43M7.43%149.26M-17.73%35.46M-2.33%37.15M0.53%38.36M94.94%38.28M101.60%138.94M150.33%43.1M
Deferred tax -670.79%-8.73M-452.36%-3.51M-9,491.30%-4.41M74.34%-2.15M68.65%-338K-154.03%-1.13M81.14%-636K99.24%-46K89.25%-8.39M92.82%-1.08M
Other non cash items -20.25%1.66M-26.52%1.58M-19.43%1.76M-1.97%8.36M-14.87%1.94M-12.61%2.08M-22.91%2.15M103.73%2.18M148.92%8.52M193.44%2.28M
Change In working capital -824.44%-63.95M-105.56%-2.22M77.41%-5.62M270.94%21.73M-108.93%-2.1M258.18%8.83M1,580.69%39.87M24.78%-24.86M-194.27%-12.71M-55.85%23.55M
-Change in receivables 98.68%-190K-178.66%-9.16M21.01%4.83M116.50%3.59M-81.06%2.33M-783.73%-14.37M137.38%11.65M179.76%3.99M3.30%-21.78M-71.54%12.28M
-Change in inventory 186.25%6.99M-50.30%3.41M-92.24%1.06M-70.65%14.17M-90.12%1.79M-161.74%-8.1M-58.81%6.87M4,023.03%13.61M2,202.53%48.27M50,516.67%18.15M
-Change in prepaid assets -124.23%-434K-661.81%-11.51M25.63%-177K131.24%1.44M124.93%1.4M137.85%1.79M-249.77%-1.51M-135.16%-238K-324.13%-4.61M-141.97%-5.6M
-Change in payables and accrued expense -338.29%-70.32M-34.20%15.04M73.17%-11.33M107.31%2.53M-494.69%-7.62M236.92%29.51M32.28%22.86M-45.33%-42.22M-187.85%-34.6M-110.22%-1.28M
-Change in other working capital ----------------------------------3K--0
Cash from discontinued investing activities
Operating cash flow -112.16%-9M-32.41%67.4M123.83%61.94M121.16%274.75M10.57%73.34M73.06%74.02M146.53%99.72M209.31%27.67M19.96%124.23M83.23%66.33M
Investing cash flow
Cash flow from continuing investing activities -6,413.95%-248.96M78.65%-8.91M-10,200.00%-18.13M87.66%-70.81M-2,569.89%-25.1M-3,282.30%-3.82M-8,949.24%-41.72M99.97%-176K-29,410.85%-573.69M-82.52%-940K
Net PPE purchase and sale -275.38%-244K-382.14%-270K-222.73%-568K71.58%-461K82.55%-164K42.48%-65K87.85%-56K-62.96%-176K16.56%-1.62M-82.52%-940K
Net business purchase and sale --------------0--0---------------572.07M--0
Net investment purchase and sale 600.90%18.82M79.27%-8.64M---17.56M---70.35M---24.93M---3.76M---41.66M--0--0--0
Cash from discontinued investing activities
Investing cash flow -6,413.95%-248.96M78.65%-8.91M-10,200.00%-18.13M87.66%-70.81M-2,569.89%-25.1M-3,282.30%-3.82M-8,949.24%-41.72M99.97%-176K-29,410.85%-573.69M-82.52%-940K
Financing cash flow
Cash flow from continuing financing activities 256.19%149.03M-152.47%-114.21M-179.28%-54.15M-132.10%-140.18M-162.66%-67.83M-205.30%-95.41M-88.75%-45.24M-86.81%68.3M589.04%436.72M39.24%-25.82M
Net issuance payments of debt 424.10%148.55M-70.86%-79.05M-163.64%-45.83M-114.89%-65.92M-83.33%-45.83M-83.34%-45.83M-85.07%-46.27M-86.09%72.02M985.36%442.68M-100.00%-25M
Net common stock issuance --0---------433.31%-75M-227.18%-25M---50M--------70.62%-14.06M76.37%-7.64M
Proceeds from stock option exercised by employees 4.55%620K357.15%5.72M13.54%4.56M-25.08%9.1M-52.79%3.24M114.86%593K-19.03%1.25M15.96%4.02M-4.40%12.15M193.42%6.86M
Net other financing activities 17.44%-142K-2,570.45%-5.88M-66.42%-12.87M-106.75%-8.36M-417.78%-233K-62.26%-172K56.95%-220K-128.74%-7.74M2.53%-4.04M---45K
Cash from discontinued financing activities
Financing cash flow 256.19%149.03M-152.47%-114.21M-179.28%-54.15M-132.10%-140.18M-162.66%-67.83M-205.30%-95.41M-88.75%-45.24M-86.81%68.3M589.04%436.72M39.24%-25.82M
Net cash flow
Beginning cash position -38.92%173.94M-15.58%229.66M36.18%239.99M-6.74%176.24M89.93%259.58M127.35%284.8M149.01%272.03M-6.74%176.24M6.97%188.97M-30.19%136.67M
Current changes in cash -331.99%-108.93M-536.34%-55.72M-110.79%-10.34M600.54%63.76M-149.50%-19.59M-321.12%-25.22M-20.31%12.77M220.15%95.79M-203.48%-12.74M680.51%39.56M
End cash Position -74.96%65.01M-38.92%173.94M-15.58%229.66M36.18%239.99M36.18%239.99M89.93%259.58M127.35%284.8M149.01%272.03M-6.74%176.24M-6.74%176.24M
Free cash flow -112.50%-9.24M-32.65%67.13M123.20%61.37M123.71%274.29M11.91%73.17M73.37%73.95M149.23%99.67M208.15%27.5M20.66%122.61M83.24%65.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data